Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Methylprednisolone 625 mg vs 1250 mg in MS Relapse
NCT01986998Phase 4Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Oct 2013
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in multiple sclerosis (MS), sponsored by Hospital Universitari Germans Trias i Pujol. Started Oct 2013; status: completed.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01986998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986998.